Nathan Brown, PhD
Director of Science
Nathan leads the Research and Application Science teams, driving the development of new methods whilst ensuring customer feedback directly shapes our research and development priorities.
Before joining Optibrium, Nathan held the role of Director of Digital Chemistry at Healx where he led the development of AI-powered computational methods for rare disease drug discovery. Prior to that, he led the Cheminformatics team at BenevolentAI and founded the In Silico Medicinal Chemistry team at The Institute of Cancer Research, where he delivered significant scientific impact on drugs in active clinical trials.
Globally recognised as a thought leader in cheminformatics and computational chemistry, Nathan is a Fellow of the Royal Society of Chemistry, and a Member of the Editorial Advisory Boards at the Journal of Chemical Information and Modeling and ChemMedChem. He invented the first multi-objective de novo molecular design system, published in 2004, and has published over 50 peer-reviewed papers and four books in the field. Nathan won the 2017 Corwin Hansch Award in recognition of his outstanding contributions to the field.
